• Home
  • News
  • An Inquiry concerning Hughie Morrison – Our Little Sister (IRE)

An Inquiry concerning Hughie Morrison – Our Little Sister (IRE)

BHA Logo

Press Release

18 May 2017

The BHA can confirm that it has issued charges against Licensed Trainer Hughie Morrison as follows:

1. Is Mr Morrison in breach of Rule (G)2.1 of the Rules of Racing by virtue of the fact that nandrolone and its metabolite, 5a-estrane-3ß,17a-diol, both Prohibited Substances pursuant to Rule (G)16, were found in a urine sample taken from OUR LITTLE SISTER (IRE) following its run in The Betway Marathon Handicap Stakes (Class 6) at Wolverhampton racecourse on 14 January 2017?

2. Should OUR LITTLE SISTER (IRE) be disqualified from the race, pursuant to Rule (A)74.2 Ground 3 of the Rules of Racing?

In accordance with the BHA’s normal practice of assisting a Trainer in circumstances such as these to establish the source of the administration, the BHA has carried out all reasonable enquiries it can with the full cooperation of Mr Morrison.

The charges will now be considered by a Disciplinary Panel. Anyone with information in relation to this matter should contact the BHA by calling RaceStraight, our confidential helpline, on 0800 085 2580 or by visiting https://www.britishhorseracing.com/racestraight/. All information will be treated in the strictest confidence and the identity of any caller will remain anonymous.

Leave a comment

Please login to leave a comment.


Legal Advisors

Upcoming Events

Copyright © LawInSport Limited 2010 - 2022. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.